01 10ASTRAZENECA
01 1010183020
01 10Blank
01 10Y
01 102035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3016
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3823
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3016
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-1777
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-2289
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-4010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-2289
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3823
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-4010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-02
Patent Expiration Date : 2035-01-02
US Patent Number : 10183020
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-1777
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2035-01-02
